Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Kessler Hails Leadership, Torti Praises Staff For Brighter Future At FDA

This article was originally published in The Tan Sheet

Executive Summary

Former Commissioner David Kessler sees the appointment of tandem leadership at FDA as a way to re-establish stability and longevity for the agency's senior management

You may also be interested in...

Sharfstein Is Acting FDA Commissioner As Hamburg Awaits Confirmation

Josh Sharfstein will begin his FDA career March 30, serving as acting commissioner while awaiting the confirmation of President Obama's nominee for the spot, Margaret Hamburg

Hamburg/Sharfstein Appointments Do Not Signal Split Duties At FDA

FDA's top leadership team will not split duties along food and medical products, sources close to the selection process say

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts